Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study.
Avancini A, Giannarelli D, Borsati A, Carnio S, Cantale O, Nepote A, Mangiapane F, Bafunno D, Galetta D, Longo V, Tregnago D, Trestini I, Belluomini L, Sposito M, Insolda J, Schena F, Milella M, Novello S, Pilotto S; partnership with WALCE (Women Against Lung Cancer in Europe). Avancini A, et al. Among authors: giannarelli d. ESMO Open. 2024 Jul;9(7):103624. doi: 10.1016/j.esmoop.2024.103624. Epub 2024 Jun 28. ESMO Open. 2024. PMID: 38943736 Free PMC article.
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation.
Belluomini L, Cesta Incani U, Smimmo A, Avancini A, Sposito M, Insolda J, Mariangela Scaglione I, Gattazzo F, Caligola S, Adamo A, Conciatori F, Bazzichetto C, Ugel S, Giannarelli D, Pilotto S, Milella M. Belluomini L, et al. Among authors: giannarelli d. Lung Cancer. 2024 Aug;194:107893. doi: 10.1016/j.lungcan.2024.107893. Epub 2024 Jul 14. Lung Cancer. 2024. PMID: 39008934 Free article.
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study.
Borsati A, Giannarelli D, Belluomini L, Ciurnelli C, Colonna A, D'Amico I, Daniele A, Del Bianco N, Toniolo L, Trestini I, Tregnago D, Insolda J, Sposito M, Lanza M, Milella M, Schena F, Pilotto S, Avancini A. Borsati A, et al. Among authors: giannarelli d, d amico i. Healthcare (Basel). 2024 Aug 17;12(16):1643. doi: 10.3390/healthcare12161643. Healthcare (Basel). 2024. PMID: 39201201 Free PMC article.
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Iacovelli R, Ciccarese C, Buti S, Zucali PA, Fantinel E, Bimbatti D, Verzoni E, Accettura C, Bonomi L, Buttigliero C, Fornarini G, Pipitone S, Atzori F, Masini C, Massari F, Primi F, Strusi A, Giudice GC, Perrino M, Maruzzo M, Milella M, Giannarelli D, Brunelli M, Procopio G, Tortora G. Iacovelli R, et al. Among authors: giannarelli d. Eur Urol. 2024 Nov;86(5):411-419. doi: 10.1016/j.eururo.2024.02.014. Epub 2024 Mar 22. Eur Urol. 2024. PMID: 38521617 Free article. Clinical Trial.
Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort.
Camarda F, Mastrantoni L, Parrillo C, Minucci A, Persiani F, Giannarelli D, Pasciuto T, Giacomini F, De Paolis E, Manfredelli M, Marchetti C, Zannoni GF, Fagotti A, Scambia G, Nero C. Camarda F, et al. Among authors: giannarelli d. ESMO Open. 2024 Dec 19;10(1):104090. doi: 10.1016/j.esmoop.2024.104090. Online ahead of print. ESMO Open. 2024. PMID: 39705839 Free PMC article.
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).
Passiglia F, Listì A, Bironzo P, Merlini A, Benso F, Napoli F, Barbu FA, Zambelli V, Tabbò F, Reale ML, Sini C, Roca E, Taveggia PA, Simionato F, Buffoni L, Mazilu L, Barbieri V, Pignataro D, Araujo A, Paz-Ares L, Felip E, Secen N, Comanescu A, Ramizi KM, Bettini AC, Scotti V, Linardou H, Mohorcic K, Meoni G, Giannarelli D, Volante M, Malapelle U, Vallone S, Scagliotti G, Righi L, Novello S. Passiglia F, et al. Among authors: giannarelli d. J Thorac Oncol. 2024 Dec 16:S1556-0864(24)02529-2. doi: 10.1016/j.jtho.2024.12.010. Online ahead of print. J Thorac Oncol. 2024. PMID: 39694416 Free article.
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer.
Boldrini L, Chiloiro G, Di Franco S, Romano A, Smiljanic L, Tran EH, Bono F, Charles Davies D, Lopetuso L, De Bonis M, Minucci A, Giacò L, Cusumano D, Placidi L, Giannarelli D, Sala E, Gambacorta MA. Boldrini L, et al. Among authors: giannarelli d. Radiat Oncol. 2024 Jul 25;19(1):94. doi: 10.1186/s13014-024-02492-9. Radiat Oncol. 2024. PMID: 39054479 Free PMC article.
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial.
Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, Guida M, Quaglino P, Guidoboni M, Marchetti P, Simonetti E, Santangelo F, Amato G, Covre A, Camerini R, Valente M, Mandalà M, Giannarelli D, Calabrò L, Maio M. Di Giacomo AM, et al. Among authors: giannarelli d. Eur J Cancer. 2024 Mar;199:113531. doi: 10.1016/j.ejca.2024.113531. Epub 2024 Jan 11. Eur J Cancer. 2024. PMID: 38271746 Free article. Clinical Trial.
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.
Perrone E, Capasso I, Giannarelli D, Trozzi R, Congedo L, Ervas E, Tarantino V, Esposito G, Palmieri L, Guaita A, van Rompuy AS, Scaglione G, Zannoni GF, Scambia G, Amant F, Fanfani F. Perrone E, et al. Among authors: giannarelli d. Gynecol Oncol. 2024 Dec;191:150-157. doi: 10.1016/j.ygyno.2024.10.010. Epub 2024 Oct 18. Gynecol Oncol. 2024. PMID: 39423552
617 results